Skip to main content
Signal8

IRADIMED CORP (IRMD)

IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

IRadimed Corporation logo

IRadimed Corporation

NASDAQ:IRMDHealthcare
Pre+0.00%$86.31
Close$86.31+0.90%AH$86.31+0.00%vs close
Mkt Cap$1.1B
Float8.26M
O/S12.79M
PM VOL204 sh
$ Vol≈$18K
RVOL0.63×
Inst Own61.6%
Div Yield1.47%
Dilution
IRadimed Corporation logoNASDAQ:IRMDPre$86.31+0.00%
FormDescription
10-Q
8-K
13G/A
Beneficial Ownership Report (Amended)
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
8-K/A
2.02,9.01
6
10-Q
8-K
8.01
3
13G
Beneficial Ownership Report
8-K
5.07
1
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
13G/A
Beneficial Ownership Report (Amended)
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
10-Q
Quarterly Report
8-K
2.02,9.01
ARS
SEC Filing
DEF 14A
Definitive Proxy Statement
4
Statement of Changes in Beneficial Ownership

1-25 of 777

…

Recent SEC filings with analysis